Status:
COMPLETED
Evaluate the Safety and Efficacy of a 5-HT4 Agonist in Chronic Constipation (ACCORD Trial)
Lead Sponsor:
Alfasigma S.p.A.
Collaborating Sponsors:
Theravance Biopharma
Conditions:
Chronic Constipation
Eligibility:
All Genders
18-64 years
Phase:
PHASE2
Brief Summary
Study 0038 compares the safety and effectiveness of an investigational drug, TD-5108 with placebo (a sugar pill) for the treatment of chronic constipation.
Eligibility Criteria
Inclusion
- Meet ROME III Criteria
Exclusion
- Constipation caused by:colonic etiology, pelvic floor dysfunction, metabolic disturbances, neurologic disturbances,concomitant medications affecting bowel function
- Chronic treatment with anticholinergics, narcotic analgesics
- Irritable Bowel Syndrome
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2007
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT00391820
Start Date
October 1 2006
End Date
May 1 2007
Last Update
July 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Breco Research
Houston, Texas, United States, 77024